Nocturnal Enuresis Medication Global Market Report 2025
상품코드:1760654
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
야뇨증 치료제 시장 규모는 향후 몇 년간 강한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 예상 성장은 어린이의 스트레스 관련 방광 기능 장애의 증가, 심리적 트라우마에 따른 이차적 야뇨증 사례의 증가, 어린이 건강 관리를 촉진하는 정부 정책, 원격 진단 및 치료를 위한 원격 의료의 성장, 의약품 접근성을 높이는 온라인 약국의 부상 등 요인에 의해 촉진될 것입니다. 예측 기간의 주요 동향으로는 의약품 제형의 발전, 새로운 전달 방법의 개발, 새로운 치료제의 승인, 복합 요법의 인기 증가, AI 및 정밀 의학을 통한 의약품 개발 일정의 가속화 등이 있습니다.
맞춤형 치료에 대한 수요가 증가함에 따라 향후 야뇨증 치료제 시장이 성장할 것으로 예상됩니다. 개인 맞춤형 치료는 개인의 고유한 유전적 특성, 생활 방식, 선호도 및 특정 건강 상태에 맞는 치료 및 건강 관리 전략을 마련하여 더 효과적인 결과를 이끌어내는 것을 의미합니다. 이러한 수요 증가는 의료 서비스 제공자가 각 환자의 유전적 구성과 건강 상태에 따라 치료를 맞춤화할 수 있게 하는 의료 기술의 발전에 의해 촉진되고 있으며, 그 결과 더 목표가 명확하고 효과적인 치료가 가능해지고 있습니다. 야뇨증 치료제의 경우, 맞춤형 의료는 환자의 의료 기록과 근본 원인을 고려해 치료 계획을 맞춤화함으로써 치료 효과와 치료 준수율을 모두 개선합니다. 예를 들어, 2024년 2월 개인화 의료 연합(Personalized Medicine Coalition)은 2023년에 희귀 질환 환자를 위한 16개의 새로운 맞춤형 치료법이 FDA 승인을 받았다고 보고했으며, 이는 2022년의 6개에서 증가한 수치입니다. 이로 인해 맞춤형 치료에 대한 수요가 야뇨증 치료제 시장 성장을 촉진하고 있습니다.
의료비 지출의 증가는 향후 몇 년 동안 야간 요실금 치료제 시장의 성장에 기여할 것으로 예상됩니다. 의료비 지출은 특정 기간 동안 개인, 정부 및 기관이 의료 서비스, 제품 및 공중 보건에 지출한 총 지출을 의미합니다. 의료비 지출의 증가는 지속적인 관리 및 치료가 필요한 만성 질환의 유병률 증가와 같은 요인에 의해 촉진되며, 이로 인해 의약품 및 전문 치료에 드는 비용이 증가합니다. 의료 지출의 증가는 연구 개발에 대한 투자 확대와 고급 치료 옵션에 대한 접근성 개선을 통해 야뇨증 치료제에 긍정적인 영향을 미칩니다. 이는 환자의 치료 접근성과 효과성을 향상시킵니다. 예를 들어 Peterson-KFF Health System Tracker에 따르면 미국 의료비는 2024년 4조 9,000억 달러에 이르고, 2023년 4조 6,700억 달러에서 5% 증가할 것으로 예측됩니다. 따라서 건강 관리 지출 증가는 야뇨증 치료제 시장의 성장을 뒷받침하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 야뇨증 치료제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 야뇨증 치료제 시장 : 성장률 분석
세계의 야뇨증 치료제 시장 실적 : 규모와 성장(2019-2024년)
세계의 야뇨증 치료제 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 야뇨증 치료제 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 야뇨증 치료제 시장 : 약제 등급별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
데스모프레신
이미프라민
옥시부티닌
병용 약물 요법
항우울제
세계의 야뇨증 치료제 시장 : 연령층별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
어린이
청소년
성인
고령자
세계의 야뇨증 치료제 시장 : 처방 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
정제
액체 솔루션
스프레이
패치
서방형 제제
세계의 야뇨증 치료제 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 야뇨증 치료제 시장 : 데스모프레신 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구정
코 스프레이
설하정
세계의 야뇨증 치료제 시장 : 이미플라민 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구정
서방형 캡슐
세계의 야뇨증 치료제 시장 : 옥시부티닌 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
즉방정
서방정
경피 패치
시럽
세계의 야뇨증 치료제 시장 : 병용 약물 요법 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
데스모프레신과 옥시부티닌
데스모프레신과 이미프라민
옥시부티닌과 이미프라민
세계의 야뇨증 치료제 시장 : 항우울제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
삼환계 항우울제
선택적 세로토닌 재흡수 억제제(SSRI)
세로토닌 및 노르에피네프린 재흡수 억제제(SNRI)
제7장 지역별, 국가별 분석
세계의 야뇨증 치료제 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 야뇨증 치료제 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
야뇨증 치료제 시장 :경쟁 구도
야뇨증 치료제 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Dr. Willmar Schwabe GmbH & Co. KG : 개요, 제품 및 서비스, 전략 및 재무 분석
Ferring Pharmaceuticals A/S : 개요, 제품 및 서비스, 전략 및 재무 분석
UroGen Pharma Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bakson Drugs and Pharmaceuticals Pvt. Ltd.
Nordic Pharma Group
Dr. Reckeweg & Co. GmbH
Chummie
Taiho Pharmaceutical Co. Ltd.
AA Pharma Inc.
Bakson Drugs and Pharmaceuticals Pvt. Ltd.
Aark Pharmaceuticals Ltd.
Alturix Ltd.
Wellesley Pharmaceuticals LLC
German Homoeo Care and Cure Pvt. Ltd.
Laboratoires Ledoux Reflexe Inc.
Global Continence Inc.
Serenity Pharmaceuticals LLC
Vantia Therapeutics Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
야뇨증 치료제 시장(2029년) : 새로운 기회를 제공하는 국가
야뇨증 치료제 시장(2029년) : 새로운 기회를 제공하는 부문
야뇨증 치료제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Nocturnal enuresis medication refers to drugs designed to treat and alleviate involuntary urination during sleep, commonly known as bedwetting, which affects both children and, in some cases, adults. The primary aim is to improve bladder control, reduce the amount of urine produced overnight, or modify the body's natural sleep response to a full bladder.
The main classes of drugs used for nocturnal enuresis include desmopressin, imipramine, oxybutynin, combined pharmacotherapy, and antidepressants. Desmopressin is a synthetic hormone that helps reduce nighttime urine production and is often prescribed for treating nocturnal enuresis (bedwetting). It is suitable for various age groups, including children, adolescents, adults, and the elderly, and comes in multiple forms such as tablets, liquid solutions, sprays, patches, and extended-release formulations. These medications are available through hospital pharmacies, retail pharmacies, and online pharmacies.
The nocturnal enuresis medication market research report is one of a series of new reports from The Business Research Company that provides nocturnal enuresis medication market statistics, including nocturnal enuresis medication industry global market size, regional shares, competitors with a nocturnal enuresis medication market share, detailed nocturnal enuresis medication market segments, market trends and opportunities, and any further data you may need to thrive in the nocturnal enuresis medication industry. This nocturnal enuresis medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nocturnal enuresis medication market size has grown strongly in recent years. It will grow from $1.53 billion in 2024 to $1.65 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historical period can be attributed to the high global prevalence of nocturnal enuresis in children, growing awareness of adult nocturnal enuresis, an increasing pediatric population, higher diagnosis rates due to enhanced screening methods, and a rising incidence of comorbid conditions.
The nocturnal enuresis medication market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The expected growth in the forecast period is driven by factors such as an increase in stress-related bladder dysfunction in children, a rise in secondary enuresis cases following psychological trauma, government initiatives promoting child healthcare, the growth of telemedicine for remote diagnosis and treatment, and the rise of e-pharmacies enhancing drug accessibility. Key trends in the forecast period include advancements in drug formulations, the development of new delivery methods, the approval of new therapeutic agents, the growing popularity of combination therapies, and the acceleration of drug development timelines through AI and precision medicine.
The growing demand for personalized care is expected to drive the growth of the nocturnal enuresis medication market in the future. Personalized care involves tailoring treatments and healthcare strategies to an individual's unique genetic profile, lifestyle, preferences, and specific health conditions, leading to more effective outcomes. This increasing demand is driven by advancements in medical technology that enable healthcare providers to customize treatments based on each patient's genetic makeup and health conditions, resulting in more targeted and effective care. In the case of nocturnal enuresis medication, personalized care involves customizing treatment plans according to a patient's medical history and underlying causes, improving both the effectiveness and adherence to therapy. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from 6 in 2022. As a result, the demand for personalized care is fueling the growth of the nocturnal enuresis medication market.
Rising healthcare expenditure is expected to contribute to the growth of the nocturnal enuresis medication market in the coming years. Healthcare expenditure refers to the total spending on medical services, products, and public health by individuals, governments, and organizations over a specific period. The increase in healthcare spending is driven by factors such as the growing prevalence of chronic diseases, which require ongoing management and treatment, leading to higher costs for medications and specialized care. The rise in healthcare expenditure supports nocturnal enuresis medication by providing more investment in research, development, and access to advanced treatment options, thereby enhancing the availability and effectiveness of care for patients. For example, the Peterson-KFF Health System Tracker reported that US health spending was projected to reach $4.9 trillion in 2024, a 5% increase from $4.67 trillion in 2023. Therefore, rising healthcare expenditure is boosting the growth of the nocturnal enuresis medication market.
Companies operating in the nocturnal enuresis medication market are focusing on advanced solutions such as orally disintegrating tablets (ODT) to improve patient convenience. Orally disintegrating tablets are solid forms of medication that dissolve quickly in the mouth without the need for water, making them ideal for patients who have difficulty swallowing pills. For example, in March 2024, Adalvo Limited, a pharmaceutical company based in Malta, launched desmopressin orally disintegrating tablets in Europe. This formulation, designed specifically for treating primary nocturnal enuresis, provides a convenient option that disintegrates rapidly in the mouth. It is particularly beneficial for pediatric and elderly patients or those with difficulty swallowing. The launch reflects Adalvo's commitment to offering differentiated pharmaceutical products and improving patient access to essential therapies through strategic partnerships.
Major players in the nocturnal enuresis medication market are Pfizer Inc., Merck & Co. Inc., Dr. Willmar Schwabe GmbH & Co. KG, Ferring Pharmaceuticals A/S, UroGen Pharma Ltd., Bakson Drugs and Pharmaceuticals Pvt. Ltd., Nordic Pharma Group, Dr. Reckeweg & Co. GmbH, Chummie, Taiho Pharmaceutical Co. Ltd., AA Pharma Inc., Bakson Drugs and Pharmaceuticals Pvt. Ltd., Aark Pharmaceuticals Ltd., Alturix Ltd., Wellesley Pharmaceuticals LLC, German Homoeo Care and Cure Pvt. Ltd., Laboratoires Ledoux Reflexe Inc., Global Continence Inc., Serenity Pharmaceuticals LLC, and Vantia Therapeutics Ltd.
North America was the largest region in the nocturnal enuresis medication market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nocturnal enuresis medication report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nocturnal enuresis medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The nocturnal enuresis medication market consists of sales of fixed-dose combination drugs, nutraceuticals, and herbal supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nocturnal Enuresis Medication Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on nocturnal enuresis medication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for nocturnal enuresis medication ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nocturnal enuresis medication market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Desmopressin; Imipramine; Oxybutynin; Combined Pharmacotherapy; Antidepressants
2) By Age Group: Children; Adolescents; Adults; Elderly
3. Nocturnal Enuresis Medication Market Trends And Strategies
4. Nocturnal Enuresis Medication Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Nocturnal Enuresis Medication Growth Analysis And Strategic Analysis Framework
5.1. Global Nocturnal Enuresis Medication PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Nocturnal Enuresis Medication Market Growth Rate Analysis
5.4. Global Nocturnal Enuresis Medication Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Nocturnal Enuresis Medication Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Nocturnal Enuresis Medication Total Addressable Market (TAM)
6.1. Global Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Desmopressin
Imipramine
Oxybutynin
Combined Pharmacotherapy
Antidepressants
6.2. Global Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Children
Adolescents
Adults
Elderly
6.3. Global Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Liquid Solutions
Sprays
Patches
Extended-Release Formulations
6.4. Global Nocturnal Enuresis Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Nocturnal Enuresis Medication Market, Sub-Segmentation Of Desmopressin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Nasal Sprays
Sublingual Tablets
6.6. Global Nocturnal Enuresis Medication Market, Sub-Segmentation Of Imipramine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Extended-Release Capsules
6.7. Global Nocturnal Enuresis Medication Market, Sub-Segmentation Of Oxybutynin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immediate-Release Tablets
Extended-Release Tablets
Transdermal Patches
Syrups
6.8. Global Nocturnal Enuresis Medication Market, Sub-Segmentation Of Combined Pharmacotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Desmopressin And Oxybutynin
Desmopressin And Imipramine
Oxybutynin And Imipramine
6.9. Global Nocturnal Enuresis Medication Market, Sub-Segmentation Of Antidepressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Nocturnal Enuresis Medication Market
9.1. China Nocturnal Enuresis Medication Market Overview
9.2. China Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Nocturnal Enuresis Medication Market
10.1. India Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Nocturnal Enuresis Medication Market
11.1. Japan Nocturnal Enuresis Medication Market Overview
11.2. Japan Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Nocturnal Enuresis Medication Market
12.1. Australia Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Nocturnal Enuresis Medication Market
13.1. Indonesia Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Nocturnal Enuresis Medication Market
14.1. South Korea Nocturnal Enuresis Medication Market Overview
14.2. South Korea Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Nocturnal Enuresis Medication Market
15.1. Western Europe Nocturnal Enuresis Medication Market Overview
15.2. Western Europe Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Nocturnal Enuresis Medication Market
16.1. UK Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Nocturnal Enuresis Medication Market
17.1. Germany Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Nocturnal Enuresis Medication Market
18.1. France Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Nocturnal Enuresis Medication Market
19.1. Italy Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Nocturnal Enuresis Medication Market
20.1. Spain Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Nocturnal Enuresis Medication Market
21.1. Eastern Europe Nocturnal Enuresis Medication Market Overview
21.2. Eastern Europe Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Nocturnal Enuresis Medication Market
22.1. Russia Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Nocturnal Enuresis Medication Market
23.1. North America Nocturnal Enuresis Medication Market Overview
23.2. North America Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Nocturnal Enuresis Medication Market
24.1. USA Nocturnal Enuresis Medication Market Overview
24.2. USA Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Nocturnal Enuresis Medication Market
26.1. South America Nocturnal Enuresis Medication Market Overview
26.2. South America Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Nocturnal Enuresis Medication Market
27.1. Brazil Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Nocturnal Enuresis Medication Market
28.1. Middle East Nocturnal Enuresis Medication Market Overview
28.2. Middle East Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Nocturnal Enuresis Medication Market
29.1. Africa Nocturnal Enuresis Medication Market Overview
29.2. Africa Nocturnal Enuresis Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Nocturnal Enuresis Medication Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Nocturnal Enuresis Medication Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Nocturnal Enuresis Medication Market Competitive Landscape And Company Profiles
